Visit our e-commerce website for Conferences, Webinars, Medical Membership, eBooks etc [More Details]

Medical Professionals Become an LDN Specialist [More Details]

Efficacy of Low-Dose Naltrexone and Predictors of Treatment Success or Discontinuation in Fibromyalgia and Other Chronic Pain Conditions: A Fourteen-Year, Enterprise-Wide Retrospective Analysis

As revised 23 March 2023


Jenny - US: LDN, CRPS and Small Fibre Neuropathy (LDN; low dose naltrexone)


Off-label pharmacological treatment for neuropathic pain: A Delphi study by the Spanish Pain Society Neuropathic Pain Task Force

Pain Pract
29 October 2022


Natasha - Australia: Chronic Pain and Cancer (LDN; low dose naltrexone)



The LDN 3: To Purchase with discounts before 1st September 2022 Go to for full details